Effect of pioglitazone, as antidiabetic agent, on atheroma regression in type 2 diabetic patients: a systematic review and meta-analysis

Effect of pioglitazone, as antidiabetic agent, on atheroma regression in type 2 diabetic patients: a systematic review and meta-analysis

Abstract Background Pioglitazone’s role in the induction of atheroma regression in diabetics was suggested by several RCT. The aim of our study was to evaluate this role through a systematic review of all RCT conducted on this subject. Methods Literature was searched for relevant studies. We include...

Full description

Bibliographic Details
Main Authors: Antoine Fakhry AbdelMassih, Ahmed Ashraf, Habiba-Allah Ismail, Bassant AbdelAzeim, Ihab Hany Barsoum, Shady Girgis, George Afdal, Nesrine AbdelAzeim, Peter Afdal, Esraa Menshawey, Rahma Menshawey, Kirollos Badr, Mariem Arsanyous
Format: Article
Language:English
Published: SpringerOpen 2021-02-01
Series:Beni-Suef University Journal of Basic and Applied Sciences
Subjects:
Pioglitazone
Antiatherogenic effect
Regenerative medicine
Metabolic syndrome
Type 2 diabetes mellitus
Online Access:https://doi.org/10.1186/s43088-021-00096-w

Internet

https://doi.org/10.1186/s43088-021-00096-w

Similar Items